Rhelion Life Sciences Corp.
TRUFF
$0.02
$0.008.42%
OTC PK
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -4.40M | -3.55M | -3.17M | -2.74M | -2.89M |
| Total Depreciation and Amortization | 258.40K | 277.70K | 379.60K | 478.20K | 561.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 2.04M | 1.11M | 652.30K | 443.00K | 379.80K |
| Change in Net Operating Assets | 351.80K | 371.00K | 1.35M | 677.50K | 875.40K |
| Cash from Operations | -1.75M | -1.80M | -795.80K | -1.14M | -1.08M |
| Capital Expenditure | -101.40K | -127.10K | -152.30K | -157.20K | -386.20K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -784.50K | -712.60K | -483.60K | -147.50K | 4.20K |
| Cash from Investing | -885.80K | -839.60K | -635.90K | -304.80K | -382.10K |
| Total Debt Issued | 4.60K | 204.30K | 27.70K | 27.70K | 581.60K |
| Total Debt Repaid | -770.60K | -695.00K | -733.30K | -767.30K | -136.50K |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -553.90K | -357.50K | -511.50K | -536.60K | 323.70K |
| Foreign Exchange rate Adjustments | 34.20K | 78.40K | 96.30K | 44.90K | 18.70K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -3.15M | -2.92M | -1.85M | -1.94M | -1.12M |